Publicaciones en las que colabora con Marta Santisteban Eslava (3)

2022

  1. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

    BMC Cancer, Vol. 22, Núm. 1

2020

  1. A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428

2002

  1. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: A phase II study

    Breast Cancer Research and Treatment, Vol. 76, Núm. 1, pp. 47-56